Literature DB >> 19363654

Establishment and characterization of a new highly metastatic human osteosarcoma cell line.

Yuxi Su1, Xiaoji Luo, Bai-Cheng He, Yi Wang, Liang Chen, Guo-Wei Zuo, Bo Liu, Yang Bi, Jiayi Huang, Gao-Hui Zhu, Yun He, Quan Kang, Jinyong Luo, Jikun Shen, Jin Chen, Xianqing Jin, Rex C Haydon, Tong-Chuan He, Hue H Luu.   

Abstract

Osteosarcoma is the most common primary malignancy of bone in children and young adults. There is a paucity of tumorigenic and highly metastatic human osteosarcoma cell lines that have not been further transformed by exogenous means. Here we establish and characterize a highly metastatic human osteosarcoma cell line that is derived from a poorly metastatic MG63 line through serial passage in nude mice via intratibial injections. The occasional pulmonary metastases developed from MG63 were harvested and repassaged in mice until a highly metastatic subline (MG63.2) was established. The parental MG63 and highly metastatic MG63.2 cells were further characterized in vitro and in vivo. MG63.2 cells demonstrated increased cell migration and invasion compared to the parental MG63 cells. Conversely, cell adhesion was significantly greater in MG63 cells when compared to the MG63.2 cells. MG63.2 cells grew at a slightly slower rate than that of the parental cells. When injected into nude mice, MG63.2 cells had a greater than 200-fold increase in developing pulmonary metastases compared to the parental MG63 cells. MG63.2 cells also formed larger primary tumors when compared to the parental MG63 cells. Further analysis revealed that ezrin expression was up-regulated in the metastatic MG63.2 cells. Interestingly, expressions of MMP-2 and MMP-9 were down-regulated, and expression of TIMP-2 was up-regulated in the MG63.2 cells. Taken together, we have established and characterized a highly metastatic human osteosarcoma cell line that should serve as a valuable tool for future investigations on the pathogenesis, metastasis, and potential treatments of human osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19363654     DOI: 10.1007/s10585-009-9259-6

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  47 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.

Authors:  Avery A Sandberg; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2003-08

2.  Cancer biology: emissaries set up new sites.

Authors:  Patricia S Steeg
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

3.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

Authors:  M P Link; A M Goorin; A W Miser; A A Green; C B Pratt; J B Belasco; J Pritchard; J S Malpas; A R Baker; J A Kirkpatrick
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

4.  Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.

Authors:  Rex C Haydon; Lan Zhou; Tao Feng; Benjamin Breyer; Hongwei Cheng; Wei Jiang; Akira Ishikawa; Terrance Peabody; Anthony Montag; Michael A Simon; Tong-Chuan He
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

5.  An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential.

Authors:  C Khanna; J Prehn; C Yeung; J Caylor; M Tsokos; L Helman
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

6.  A gene involved in control of human cellular senescence on human chromosome 1q.

Authors:  P J Hensler; L A Annab; J C Barrett; O M Pereira-Smith
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

7.  Some prognostic and epidemiologic factors in canine osteosarcoma.

Authors:  W Misdorp; A A Hart
Journal:  J Natl Cancer Inst       Date:  1979-03       Impact factor: 13.506

Review 8.  The role of the CD44/ezrin complex in cancer metastasis.

Authors:  Tracey A Martin; Gregory Harrison; Robert E Mansel; Wen G Jiang
Journal:  Crit Rev Oncol Hematol       Date:  2003-05       Impact factor: 6.312

9.  Imaging findings of extrapulmonary metastases of osteosarcoma.

Authors:  Seung Ja Kim; Jung-Ah Choi; Sang Hyun Lee; Ja Young Choi; Sung Hwan Hong; Hye Won Chung; Heung Sik Kang
Journal:  Clin Imaging       Date:  2004 Jul-Aug       Impact factor: 1.605

10.  Single and multiple metachronous osteosarcoma tumors after therapy.

Authors:  Norman Jaffe; Peggy Pearson; Alan W Yasko; Patrick Lin; Cynthia Herzog; Kevin Raymond
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

View more
  44 in total

1.  Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.

Authors:  Dan Guo; Jiayi Huang; Jianping Gong
Journal:  Mol Cell Biochem       Date:  2011-12-14       Impact factor: 3.396

2.  Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma.

Authors:  Ling Ren; Sung-Hyeok Hong; Qing-Rong Chen; Joseph Briggs; Jessica Cassavaugh; Satish Srinivasan; Michael M Lizardo; Arnulfo Mendoza; Ashley Y Xia; Narayan Avadhani; Javed Khan; Chand Khanna
Journal:  Cancer Res       Date:  2011-12-06       Impact factor: 12.701

3.  Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer.

Authors:  Bai-Cheng He; Jian-Li Gao; Bing-Qiang Zhang; Qing Luo; Qiong Shi; Stephanie H Kim; Enyi Huang; Yanhong Gao; Ke Yang; Eric R Wagner; Linyuan Wang; Ni Tang; Jinyong Luo; Xing Liu; Mi Li; Yang Bi; Jikun Shen; Gaurav Luther; Ning Hu; Qixin Zhou; Hue H Luu; Rex C Haydon; Yingming Zhao; Tong-Chuan He
Journal:  Mol Pharmacol       Date:  2010-10-26       Impact factor: 4.436

4.  IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.

Authors:  Jinchang Lu; Guohui Song; Qinglian Tang; Changye Zou; Feng Han; Zhiqiang Zhao; Bicheng Yong; Junqiang Yin; Huaiyuan Xu; Xianbiao Xie; Tiebang Kang; YingLee Lam; Huiling Yang; Jingnan Shen; Jin Wang
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

5.  Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma.

Authors:  Ian Bayles; Malgorzata Krajewska; W Dean Pontius; Alina Saiakhova; James J Morrow; Cynthia Bartels; Jim Lu; Zachary J Faber; Yuriy Fedorov; Ellen S Hong; Jaret M Karnuta; Brian Rubin; Drew J Adams; Rani E George; Peter C Scacheri
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

6.  A novel noninvasive method for evaluating experimental lung metastasis in mice.

Authors:  Arnulfo Mendoza; Radhika Gharpure; John Dennis; Joshua D Webster; Jeremy Smedley; Chand Khanna
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

7.  Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation.

Authors:  Yi Shu; Chao Yang; Xiaojuan Ji; Linghuan Zhang; Yang Bi; Ke Yang; Mengjia Gong; Xing Liu; Qi Guo; Yuxi Su; Xiangyang Qu; Guoxin Nan; Chen Zhao; Zongyue Zeng; Xinyi Yu; Ruyi Zhang; Shujuan Yan; Jiayan Lei; Ke Wu; Ying Wu; Liping An; Shifeng Huang; Cheng Gong; Chengfu Yuan; Wei Liu; Bo Huang; Yixiao Feng; Bo Zhang; Zhengyu Dai; Yi Shen; Wenping Luo; Xi Wang; Rex C Haydon; Hue H Luu; Russell R Reid; Jennifer Moriatis Wolf; Michael J Lee; Tong-Chuan He; Yasha Li
Journal:  J Cell Biochem       Date:  2018-08-04       Impact factor: 4.429

8.  Minnelide reduces tumor burden in preclinical models of osteosarcoma.

Authors:  Sulagna Banerjee; Venugopal Thayanithy; Veena Sangwan; Tiffany N Mackenzie; Ashok K Saluja; Subbaya Subramanian
Journal:  Cancer Lett       Date:  2013-03-14       Impact factor: 8.679

9.  Establishment and characterization of a new highly metastatic human osteosarcoma cell line derived from Saos2.

Authors:  Lin Du; Qiming Fan; Bing Tu; Wei Yan; Tingting Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

10.  Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla.

Authors:  Jinhua Wang; Hongmei Zhang; Wenwen Zhang; Enyi Huang; Ning Wang; Ningning Wu; Sheng Wen; Xian Chen; Zhan Liao; Fang Deng; Liangjun Yin; Junhui Zhang; Qian Zhang; Zhengjian Yan; Wei Liu; Zhonglin Zhang; Jixing Ye; Youlin Deng; Hue H Luu; Rex C Haydon; Tong-Chuan He; Feng Deng
Journal:  Stem Cells Dev       Date:  2014-03-21       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.